N4 Pharma PLC risk profile
47 Elevated one input has moved against it
Measured 1 September 2026 from N4P's filed statements. Recomputed nightly.
47 (Elevated), driven by Competitive position at 69, over 3 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 58 | Elevated | Volatile | One-year price volatility — 103.1% |
| Operating pressure | 0 | Contained | Stable | Costs outgrowing revenue — -285.6 percentage points |
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | Reads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company. | |||
| Competitive position | 69 | Stretched | Stable | Operating-margin gap against peers — -15,695.4 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.